Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance - SPEED 2027-2032

This presolicitation notice is prepared in accordance with Revolutionary FAR Overhaul 5.101. (1) Points of contact. H. Dale Bish: uwo8@cdc.gov; 404.498.1312 Henrietta Fumbah: ehu0@cdc.gov, 770.488.8239 (2) Set-asides. Small business set-asides are applicable by domain. Domain 1: 25% Small Business Set-Aside (Partial Small Business Set-Aside) Domain 2: 25% Small Business Set-Aside Aside (Partial Small Business Set-Aside) Domain 3: 25% Small Business Set-Aside Aside (Partial Small Business Set-Aside) Domain 4: 25% Small Business Set-Aside Aside (Partial Small Business Set-Aside) Domain 5: 100% Small Business Set-Aside (Total Small Business Set-Aside) (3) Codes for services or supplies. The following NAICS codes and size standards are anticipated: NAICS 541690 Other Scientific and Technical Consulting Services ($19M) NAICS 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (1,000 Employees) NAICS 611430 Professional and Management Development Training ($15M) (4) Description. (i) The Centers for Disease Control and Prevention (CDC), National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Division of Healthcare Quality Promotion (DHQP), announces its intent to compete a new Indefinite-Delivery/Indefinite-Quantity (IDIQ) contract vehicle titled �Safety, Prevention, Epidemiology, and Education Development for Health Care and Antimicrobial Resistance (SPEED).� SPEED will provide CDC with an "as needed" mechanism to obtain healthcare epidemiology, health behavior, and healthcare-associated infection research support across five functional domains: (1) Domestic Antimicrobial Resistance, Infection Prevention and Control, and Adverse Events Services; (2) Healthcare Information Technology and Data Solutions Services; (3) Global Antimicrobial Resistance and Infection Prevention and Control Services; (4) Emergency Preparedness, Response Services, and Healthcare System Resilience Services; and (5) Workforce Training, Message Development, Dissemination, and Testing Services. The anticipated ordering period (period of performance) for the SPEED IDIQ is a 60-month period beginning on March 30, 2027 and ending March 29, 2032. Offerors may submit proposals to one or more domains and will be evaluated on technical approach including existing infrastructure and capacity, staffing approach, management approach, similar experience, price, and past performance. To ensure continuity of critical healthcare epidemiology and infection prevention research support with no lapse in service, DHQP extended the current Safe Healthcare, Epidemiology, Prevention Research Development (SHEPheRD) Program contracts through March 29, 2027, the day immediately preceding the SPEED anticipated effective start date. This extension allows CDC to maintain uninterrupted access to essential scientific, technical, and programmatic support while the SPEED solicitation, evaluation, and award process is completed. DHQP intends for SPEED to fully replace SHEPheRD upon award. CDC will provide further information regarding the solicitation timeline, evaluation criteria, and instructions for interested offerors in forthcoming notices. Interested parties are encouraged to monitor SAM.gov for the official solicitation and any applicable updates. SPEED shall consist of 5 Domains briefly described as follows: Domain 1: Domestic Antimicrobial Resistance, Infection Prevention and Control, and Adverse Events Services. The purpose of this domain is to obtain services that support the design, execution, and assessment of healthcare and community epidemiology research initiatives addressing antimicrobial resistance (AR), infection prevention and control (IPC), and adverse events domestically within U.S. healthcare settings and communities. These implementation services include developing and implementing study protocols, conducting clinical and epidemiologic investigations, evaluating outcomes, and translati…